Combination therapy with carfilzomib, lenalidomide and dexamethasone (KRd) results in an unprecedented purity of the stem cell graft in newly diagnosed patients with myeloma

Based on available data, most multiple myeloma patients have residual myeloma cells in their autologous hematopoietic progenitor cells (HPC) grafts during collection for autologous stemcell transplant. However, available literature is based on older induction regimens, e.g., adriamycin and dexametha...

Full description

Saved in:
Bibliographic Details
Published in:Bone Marrow Transplant
Main Authors: Tageja, Nishant, Korde, Neha, Kazandjian, Dickran, Manasanch, Elisabet, Bhutani, Manisha, Kwok, Mary, Mailankody, Sham, Yuan, Constance, Stetler-Stevenson, Maryalice, Leitman, Susan F., Sportes, Claude, Landgren, Ola
Format: Artigo
Language:Inglês
Published: 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6740327/
https://ncbi.nlm.nih.gov/pubmed/29728700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41409-018-0170-0
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items